TASIGNA

Capsule, hard, 200mg
RestrictedActive license

Active substance (INN)

nilotinib

Pharmaceutical form

Pharmaceutical formCapsule, hard
Strength200mg
PackagingUkupno 112 kapsula, tvrdih u blisteru (7x4) u kutiji, 4 kutije u zbirnoj kutiji
ManufacturerNovartis Pharma Stein AG, Switzerland
Therapeutic groupAntineoplastic and immunomodulating agents (L01XE08)
Marketing authorization holder"NOVARTIS PHARMA SERVICES AG" DIO STRANOG DRUŠTVA PODGORICA
Authorization dateJanuary 16, 2017

Analogs in Montenegro

6

Other medicines with the same active substance

NILMATRx
Capsule, hard, 150mgGalenika a.d. Beograd
NILMATRx
Capsule, hard, 200mgGalenika a.d. Beograd
NILOTINIB STADARx
Capsule, hard, 50mgStada Arzneimittel AG
NILOTINIB STADARx
Capsule, hard, 150mgStada Arzneimittel AG
NILOTINIB STADARx
Capsule, hard, 200mgStada Arzneimittel AG
TASIGNARx
Capsule, hard, 150mgNovartis Pharmaceutical Manufacturing LLC
Source: CInMED register